WFIRM Summer Scholars Research Day
Research Day on August 8, 2014 marked the conclusion of this year's 10-week program. Our scholars gave presentations and created posters for the research projects they worked on this summer at our institute.
International Perinatal Stem Cell Society
May 7, 2014 - The International Perinatal Stem Cell Society hosted their
inaugural annual conference, co-hosting the event with the Regenerative
Medicine Foundation in San Francisco. Sean Murphy, PhD, a Research Fellow at WFIRM, is one of the society's founders and serves as the Director and Secretary. This one-day program highlighted the work
of leading groups from industry, research and medicine and its international
appeal demonstrated by speakers from five different countries, including the UK,
Australia, Italy, Finland and the United States. The session covered topics
including therapeutic applications of perinatal cells from the umbilical cord
blood, Wharton’s jelly, placental tissue, amnion membranes and amniotic fluid.
In addition to updates in current perinatal stem cell research, speakers
covered recent advances and current trends in clinical manufacturing, banking
and commercialization of perinatal tissue and cells. Read more about the
conference and society here. Research Day on August 8, 2014 marked the conclusion of this year's 10-week program. Our scholars gave presentations and created posters for the research projects they worked on this summer at our institute.
Ned Holland, ASA Visits WFIRM
May 22, 2014 - Mr. Ned Holland, Assistant Secretary for Administration, U.S. Department of Health and Human Services, visits Wake Forest Institute for Regenerative Medicine. Mr. Holland was in the area for the North Carolina Biotechnology Center's Triad BioNight 2014 where he participated as the event's keynote speaker.
AFIRM II Launch Event
Feb. 25, 2014 – The Armed Forces Institute of Regenerative Medicine II program was officially launched today at an event at Wake Forest Biotech Place. The $75 million effort, being led by Wake Forest Institute for Regenerative Medicine, involves over 30 institutions and will apply regenerative medicine to battlefield injuries. Special guests Major General Joseph Caravalho Jr., M.D. and North Carolina Senator Phil Berger made remarks at the event and local business, civic and political leaders attended. AFIRM II researchers will work to develop clinical therapies focusing on restoring function to limbs, reconstruction for facial and skull injuries, skin regeneration for burn injuries, treatments to prevent rejection of transplants and reconstruction of genital and urinary organs.
WFIRM Annual Retreat
The institute's annual scientific retreat, held Feb. 10-11, 2014, is an opportunity for its researchers and their industry and academic partners to gather as a group to the share research results and discuss future directions. This collaborative atmosphere, where scientists from many different disciplines interact and discuss projects, often ignites new ideas and reveals potential paths to discovery. In addition, the retreat provides the institute's students and junior researchers the opportunity to report their work in an academic setting - experience that will be valuable in their future careers. The theme of the 2014 retreat focused on team building and team-based science. The retreat provides many opportunities to explore collaborative opportunities and includes the presentation of research abstracts, a poster session and breakout sessions to brainstorm new ideas.
WFIRM is grateful to its corporate and academic allies for providing generous financial support of the 2014 scientific retreat:
The following industry partners participated as exhibitors at the retreat:
Governor McCrory Visits WFIRM
AFIRM News Release
Dec. 3, 2013 - N.C. Gov. Pat McCrory visited the institute to
learn more about two grants - totaling $100 million - that are being
led by Wake Forest Institute for Regenerative Medicine. One effort,
the Armed Forces Institute for Regenerative Medicine, works to
apply regenerative medicine to battlefield injuries. Projects at
the institute include work to engineer muscle in the lab, print
skin cells directly onto burn wounds and "print" muscle and other
tissue that can be used on reconstructive surgeries. The second
grant - the Body on a Chip effort - works to accelerate the
development of new therapies and antidotes to biological and
chemical weapons. The goal is to build a miniaturized system of
human organs to model the body's responses to harmful agents and
potential therapies. McCrory addressed institute researchers and
talked about the importance of converting research into patents and
into solutions that can help patients.